Surface marker profiles on lung lymphocytes may predict the mechanism of immune-mediated pneumonitis triggered by tumor-infiltrating lymphocytes in lung cancer patients treated with pembrolizumab

Lung Cancer. 2018 Apr:118:171-172. doi: 10.1016/j.lungcan.2018.02.012. Epub 2018 Feb 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma of Lung / diagnosis
  • Adenocarcinoma of Lung / drug therapy
  • Adenocarcinoma of Lung / immunology*
  • Adrenal Cortex Hormones / administration & dosage
  • Aged
  • Anti-Inflammatory Agents / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • B7-H1 Antigen / immunology
  • B7-H1 Antigen / metabolism
  • Drug-Related Side Effects and Adverse Reactions / diagnosis
  • Drug-Related Side Effects and Adverse Reactions / immunology*
  • Flow Cytometry
  • Humans
  • Immunotherapy / adverse effects
  • Immunotherapy / methods*
  • Lung / drug effects*
  • Lung / immunology
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / immunology*
  • Lymphocytes, Tumor-Infiltrating / immunology*
  • Male
  • Middle Aged
  • Pneumonia / diagnosis
  • Pneumonia / etiology
  • Pneumonia / immunology*

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • B7-H1 Antigen
  • CD274 protein, human
  • pembrolizumab